|
WO2010102393A1
|
|
2-indolyl imidazo [4,5-d]phenanthroline derivatives and their use to inhibit angiogenesis
|
|
US2010204305A1
|
|
Small interfering rna molecules against ribonucleotide reductase and uses thereof
|
|
CN101248072A
|
|
2-indolyl imidazo[4,5-d]phenanthroline derivatives and their use in the treatment of cancer
|
|
WO2005047266A1
|
|
Aryl imidazoles and their use as anti-cancer agents
|
|
US2005192443A1
|
|
Biological response modifier for the treatment of cancer
|
|
CA2496241A1
|
|
2,4,5-trisubstituted imidazoles and their use as anti-microbial agents
|
|
CN1688194A
|
|
2,4,5-trisubstituted imidazoles and their use as anti-microbial agents
|
|
US2004101569A1
|
|
Immunomodulating compositions from bile
|
|
CA2451674A1
|
|
Biological response modifier composition and uses thereof
|
|
WO02102363A1
|
|
Biological response modifier composition and uses thereof
|
|
CA2428145A1
|
|
Combination preparation of a biological response modifier and an anticancer agent and uses thereof
|
|
AU1487602A
|
|
Combination preparation of a biological response modifier and an anticancer agent and uses thereof
|
|
US6551623B1
|
|
Immunomodulating compositions from bile
|
|
AU9724298A
|
|
Immunomodulation compositions from bile
|
|
ZA9806224B
|
|
Immunomodulating compositions for the treatment of viral disorders
|
|
AU4873996A
|
|
Immunomodulating compositions from bile for the treatment of immune system disorders
|
|
NZ273258A
|
|
Immunomodulator composition with components less than 3000 D that are extractable from bile, stimulate monocytes and macrophages and modulate TNF
|
